Pelacarsen
CTQJ230A12304
Phase 3 small_molecule active
Quick answer
Pelacarsen for Atherosclerotic Cardiovascular Disease (ASCVD) is a Phase 3 program (small_molecule) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Atherosclerotic Cardiovascular Disease (ASCVD)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active